Wedmont Private Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
3,086
+12
+0.4% +$6.73K 0.05% 216
2026
Q1
$1.82M Buy
3,074
+108
+4% +$69.3K 0.06% 179
2025
Q4
$2.12M Buy
2,966
+26
+0.9% +$17.7K 0.07% 155
2025
Q3
$1.84M Buy
2,940
+51
+2% +$31K 0.07% 175
2025
Q2
$1.56M Sell
2,889
-32
-1% -$15.3K 0.07% 190
2025
Q1
$1.14M Buy
2,921
+374
+15% +$162K 0.06% 206
2024
Q4
$1.06M Sell
2,547
-295
-10% -$129K 0.06% 207
2024
Q3
$1.34M Buy
2,842
+189
+7% +$91.8K 0.08% 163
2024
Q2
$1.31M Buy
2,653
+76
+3% +$38.2K 0.08% 154
2024
Q1
$1.34M Buy
2,577
+35
+1% +$19.1K 0.1% 138
2023
Q4
$1.38M Buy
2,542
+822
+48% +$386K 0.11% 115
2023
Q3
$761K Sell
1,720
-13
-0.8% -$6.48K 0.08% 171
2023
Q2
$930K Buy
1,733
+19
+1% +$9.11K 0.1% 135
2023
Q1
$818K Buy
1,714
+62
+4% +$29.7K 0.11% 136
2022
Q4
$740K Buy
+1,652
New +$641K 0.11% 143
2022
Q2
Sell
-587
Closed -$322K 359
2022
Q1
$322K Buy
+587
New +$309K 0.07% 222

Other funds holding IDXX

Wedmont Private Capital's IDXX Position: Q2 2026 in Review

Wedmont Private Capital increased its Idexx Laboratories (IDXX) stake by 0.39% in Q2 2026, buying an estimated $6.73K and bringing the position to 3,086 shares worth $1.74M. The position accounts for 0.05% of the portfolio, ranked #216.

Wedmont Private Capital first reported a position in IDXX in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.12M in Q4 2025. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Wedmont Private Capital held 3,086 shares of Idexx Laboratories worth $1.74M as of Q2 2026.
  • Wedmont Private Capital bought 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.05% of Wedmont Private Capital's portfolio in Q2 2026, its #216 holding.
  • Wedmont Private Capital first reported a position in Idexx Laboratories in Q1 2022 and has held it in 16 quarters since.
  • Wedmont Private Capital's Idexx Laboratories position peaked at $2.12M in Q4 2025.
  • 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.